MAX BioPharma Competitors and Similar CompaniesClear all

BioCryst Pharmaceuticals's competitors and similar companies include Aptuit, Bioiberica and Boston Analytical.

	BioCryst Pharmaceuticals BioCryst Pharmaceuticals designs, optimizes and develops novel small-molecule drugs that block key enzymes to treat rare diseases.	Aptuit Aptuit is a pharmaceutical services company that delivers early discovery to mid-phase drug development solutions.	Bioiberica Bioiberica is a life science company engaged in the identification, extraction, and development of animal-derived biomolecules.	Boston Analytical Boston Analytical is a company that provides analytical testing services to support CMC for drug development and release testing.
Founding Date	Founding Date 1986	Founding Date 1993	Founding Date 1975	Founding Date 1987
Type	Type Public	Type Subsidiary	Type Subsidiary	Type Subsidiary
Tags	Tags Healthcare biotech drug development life sciences pharma	Tags Healthcare biotech drug development life sciences pharma	Tags Healthcare biotech drug development life sciences pharma	Tags Healthcare biotech drug development life sciences pharma
Locations	Locations Durham, US HQ Hoover, US	Locations Greenwich, US HQ Verona, IT Reinach, CH Milton, GB	Locations Esplugues de Llobregat, ES HQ Barcelona, ES Palafolls, ES	Locations Salem, US HQ
Employees	Employees 14040% increase	Employees 761	Employees 332	Employees 2441% decrease
Financial
Revenue (est.)	Revenue (est.) $874.8m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) $346.7m (FY, 2018)	Revenue (est.) N/A
Cost of goods	Cost of goods $19.1m (FY, 2025)	Cost of goods N/A	Cost of goods $190.3m (FY, 2018)	Cost of goods N/A
Gross profit	Gross profit $855.8m (FY, 2025)	Gross profit N/A	Gross profit $156.4m (FY, 2018)	Gross profit N/A
Net income	Net income $263.9m (FY, 2025)	Net income N/A	Net income $40.5m (FY, 2018)	Net income N/A